Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-04-19FDA Approved: LAMIVUDINE — Original Application (Strides Pharma Science Limited)
FDA approved Strides Pharma Science Limited's original ANDA for lamivudine, a generic antiviral used to treat HIV-1 infection and chronic he…
-
CLINICAL_TRIALS trial_result · 2018-04-19Clinical Trial Update: Study for Consolidation Period of Chronic Hepatitis B
A clinical trial investigating the consolidation period for chronic hepatitis B has completed. The update provides limited detail on outcome…
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B (China) [Phase 3]
Phase 3 trial comparing Tenofovir alafenamide to Tenofovir disoproxil fumarate for treating hepatitis B in HBeAg-negative chronic hepatitis …
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B [Phase 2]
Phase 2 trial comparing tenofovir alone versus tenofovir with emtricitabine for chronic hepatitis B; study terminated with results posted in…
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B (China) [Phase 3]
This Phase 3 trial compares Tenofovir alafenamide (TAF) with Tenofovir disoproxil fumarate (TDF) for treating chronic hepatitis B in HBeAg-p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-04-12Clinical Trial Update: Sysmex-XN 20 Analyser to Assess Lymphocyte Subsets and Other Haematological Parameters in Chronic/Acute Viral Infections
This clinical trial update describes evaluating the Sysmex-XN 20 hematology analyser to assess lymphocyte subsets and other haematological p…
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers [NA]
Pilot study investigating gene expression profiling of immune response to Hepatitis B vaccination in healthy volunteers; trial completed wit…
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Immunosenescence and Hepatitis B Virus (HBV) Vaccine Efficacy in Chronic Renal Disease Patient [NA]
This clinical trial update indicates that the study evaluating immunosenescence and Hepatitis B vaccine efficacy in patients with chronic ki…
-
CLINICAL_TRIALS research · 2018-04-02Clinical Trial Update: Hepatitis B Patients Under Oral Nucleos(t)Ide Treatment With Intermittent Assessment of Kidney Function
An update on an ongoing clinical trial evaluating chronic hepatitis B patients treated with oral nucleos(t)ide therapies and intermittent ki…
-
CLINICAL_TRIALS trial_result · 2018-03-26Clinical Trial Update: An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB) [Phase 4]
An open-label, multicenter Phase IV study of Adefovir Dipivoxil in Korean patients with chronic hepatitis B has completed and posted results…
-
CLINICAL_TRIALS research · 2018-03-20Clinical Trial Update: Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of Age [NA]
Clinical trial update examining anti-Hepatitis B antibodies at 12-18 months after birth Hepatitis B vaccination and coadministration of a DT…
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) [Phase 3]
Phase 3 immunogenicity and safety study assessing concomitant administration of ProQuad and Infanrix Hexa has been completed and results pos…
-
CLINICAL_TRIALS research · 2018-03-09Clinical Trial Update: To Study the Effect of Adding on Pegylated Interferon (PEG-INF) Therapy for Patients Diagnosed With Chronic Hepatitis B [Phase 4]
A Phase 4 clinical trial update examining adding pegylated interferon therapy for patients with chronic hepatitis B.
-
CLINICAL_TRIALS trial_result · 2018-03-05Clinical Trial Update: EYP001a Food Effect Study in Subjects With Chronic Hepatitis B Virus (HBV) Infection [Phase 1]
Phase 1 food-effect study of EYP001a in adults with chronic hepatitis B has completed.
-
FDA approval · 2018-03-02FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Original Application (Quinn Pharmaceuticals)
FDA approves an original ANDA for a generic tenofovir disoproxil fumarate from Quinn Pharmaceuticals for the treatment of HIV infection and …
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Efficacy and Safety of Combination Therapy of Thymalfasin and Entecavir in HBeAg-positive ETV-experienced Patients [Phase 4]
Phase 4 trial evaluating the efficacy and safety of combining thymosin alpha-1 with entecavir in HBeAg-positive, entecavir-experienced chron…
-
CLINICAL_TRIALS trial_result · 2018-02-20Clinical Trial Update: Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B [Phase 4]
Phase 4 trial comparing tenofovir plus entecavir versus tenofovir alone in adefovir-resistant chronic hepatitis B.
-
CLINICAL_TRIALS trial_result · 2018-02-13Clinical Trial Update: Safety and Efficacy of HEPLISAV™ Hepatitis B Virus Vaccine Compared With Engerix-B® Vaccine [Phase 3]
Phase 3 trial comparing HEPLISAV vaccine to Engerix-B for hepatitis B; study completed with results posted in 2018.
-
FDA approval · 2018-01-26FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's generic Tenofovir disoproxil fumarate under an Original Application for use in HIV-1 infecti…
-
FDA approval · 2018-01-26FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for Tenofovir disoproxil fumarate from Aurobindo Pharma Limited, authorizing a generic version of the …
-
FDA approval · 2018-01-26FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Original Application (Cipla USA Inc.)
FDA approved the original generic application for tenofovir disoproxil fumarate (Cipla USA Inc.), enabling a generic version of the HIV and …
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAg [Phase 3]
Phase 3 trial evaluating hepatitis B surface antibody response after HBV vaccination in chronic hepatitis B patients who have lost HBsAg.
-
CLINICAL_TRIALS trial_result · 2017-12-29Clinical Trial Update: Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B [Phase 4]
Phase 4 trial update reporting efficacy and safety of entecavir maleate tablets in Chinese patients with chronic hepatitis B.
-
CLINICAL_TRIALS trial_result · 2017-12-18Clinical Trial Update: A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays [NA]
Clinical trial update for an adult hepatitis B study supporting development of immunological assays; study status completed with results pos…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Observational Study of Immune Response to Hepatitis B Childhood Booster
Completed observational study evaluating immune response to a Hepatitis B childhood booster in healthy participants.